KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
83 hedge funds and large institutions have $118M invested in Kindred Biosciences, Inc. in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 77 → 83 (+6)
Holders
83
Holding in Top 10
–
Calls
$534K
Puts
$1K
Top Buyers
| 1 | +$3.76M | |
| 2 | +$3.69M | |
| 3 | +$905K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$605K |
| 5 |
HP
Hound Partners
New York
|
+$359K |
Top Sellers
| 1 | -$7.59M | |
| 2 | -$1.34M | |
| 3 | -$1.16M | |
| 4 |
AI
Ariel Investments
Chicago,
Illinois
|
-$1.09M |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$517K |